PD-L1 Status in Gastric Cancers, Association with the Transcriptional, Growth Factors, AKT/mTOR Components Change, and Autophagy Initiation

Autor: Alexey Dobrodeev, Sergei Afanas’ev, L. V. Spirina, Dmitry Kostromitsky, Olga V Cheremisina, Alexandra Avgustinovich, Maxim Volkov

Publikováno v: International Journal of Molecular Sciences, Vol 22, Iss 11176, p 11176 (2021)
International Journal of Molecular Sciences
Volume 22
Issue 20

Introduction: The programmed death receptor ligand 1 (PD-L1) immunohistochemistry (IHC) assay is a widely used selection method for pembrolizumab treatment in gastric cancer (GC) patients. PD-L1 is the main regulator of immunity in oncogenesis. Mater

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a688b59aeb6683480132d95296105a1d
https://doi.org/10.3390/ijms222011176